Summary: Researchers have identified a connection between the immune regulator STAT1 and hyperactive behaviors in mice, offering fresh insight into mechanisms that may underlie neurodevelopmental conditions such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). STAT1, a central mediator of interferon-driven immune responses, also affects neuronal function—most notably in dopamine-producing cells that control motivation, reward processing, and motor activity.
In mouse models engineered for prolonged STAT1 activity, scientists observed increased locomotor activity alongside reduced neural responsiveness and a lower number of neurons in brain regions tied to learning and reward. These findings point to STAT1 signaling as a potential therapeutic target for addressing certain neurobehavioral symptoms.
Key Facts:
- Chronic activation of STAT1 in dopamine neurons produced hyperactivity and coincided with fewer neurons and suppressed activity in the dorsal striatum (caudate putamen), an area central to learning and reward.
- The study illustrates a direct line of communication between immune signaling pathways and brain development, reinforcing the idea that immune regulators can influence neuronal circuits.
- Ongoing research will investigate whether selectively modulating STAT1 can become a viable strategy for treating aspects of ASD, ADHD, or related neurodevelopmental disorders.
Source: Duke University
Overview: Building on a growing body of work that links immune activity with brain development, a team at Duke Health has shown how prolonged activity of the STAT1 pathway can lead to hyperactive behaviors in mice. The study appears in Brain, Behavior, and Immunity and focuses on the role of STAT1 as an on-off regulator with functions in both immunity and neuronal regulation.
“Many signaling pathways first characterized in immune cells also have important roles in the brain,” said Anthony Filiano, Ph.D., assistant professor of Neurosurgery and Pathology at Duke University School of Medicine and a faculty member in the Marcus Center for Cellular Cures. “This cross-talk between immune and nervous systems is significant, and it is promising because immune pathways are often amenable to targeted therapies.”
Researchers collaborated with Columbia University colleagues to generate mice carrying a STAT1 gain-of-function mutation. By selectively increasing STAT1 signaling in distinct brain cell populations, they examined behavioral and anatomical consequences. When STAT1 activity was prolonged in neurons starting from embryonic development, mice displayed pronounced hyperactivity and showed reduced neuronal counts and neural activity in the caudate putamen, a dorsal striatal region that integrates motor control with learning and reward.
Targeting the STAT1 gain-of-function mutation specifically to dopaminergic neurons, which project to the caudate putamen, reproduced several hyperactive behaviors even without an overall loss of neuron numbers—indicating that disturbed STAT1 signaling in dopamine-producing cells can alter behavior primarily by changing neuronal function. Conversely, driving prolonged STAT1 signaling broadly in excitatory neurons, inhibitory neurons, or in microglia did not produce the same hyperactive phenotype, underscoring the neuron- and cell-type-specific nature of the effect.
Filiano emphasized the translational potential: “These results suggest STAT1 activity in dopamine neurons influences behavior. Before considering therapies that target this pathway, we need a detailed understanding of STAT1’s specific roles and downstream effects so interventions can be precise and safe.”
The study team includes Danielle N. Clark, Shelby Brown, Li Xu, Rae-Ling Lee, Joey V. Ragusa, Zhenghao Xu, and Joshua D. Milner, among others. Funding came from the National Institutes of Health (NS123084), the Marcus Foundation, and the intramural research program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
About this genetics, ADHD, and autism research news
Author: Sarah Avery, Duke University
Source: Duke University
Contact: Sarah Avery – Duke University
Image: Image credited to Neuroscience News
Original Research: Open access. “Prolonged STAT1 signaling in neurons causes hyperactive behavior” by Anthony Filiano et al., Brain, Behavior, and Immunity.
Abstract
Prolonged STAT1 signaling in neurons causes hyperactive behavior
The interferon-induced STAT1 signaling cascade is a canonical immune pathway that also contributes to neuronal regulation. Elevated STAT1 activity has been observed in postmortem brain tissue from people with autism spectrum disorder and schizophrenia, and over-activation leads to pathological transcriptional changes. How those transcriptional alterations translate into behavioral outcomes was previously unclear.
To test whether sustained STAT1 signaling in neurons could drive behavioral traits linked to neurodevelopmental disorders, the investigators developed a mouse model harboring the clinical STAT1 gain-of-function mutation T385M restricted to neurons. These mice demonstrated marked hyperactivity, reduced neuronal activity, and fewer neurons in the caudate putamen. When the same mutation was restricted only to dopaminergic neurons, several hyperactive behaviors emerged without a detectable loss in neuron number, suggesting that dysregulated STAT1 in dopamine neurons can change behavior by altering neuronal function.
Importantly, prolonged STAT1 signaling in all excitatory neurons, inhibitory neurons, or microglia did not produce hyperactivity, highlighting a neuron- and cell-type-specific mechanism. Overall, the study positions STAT1 signaling in neurons—and particularly in dopaminergic circuits—as a key regulator of striatal activity and certain motor behaviors associated with neurodevelopmental disorders.